CAH
Cardinal Health, Inc
ACTIONABLEMethodology gates passed
Position levels
Currenttoday
USD 278.14
Buy <=wait / entry
USD 198.33
Trim >=take some off
USD 245.00
Thesis breakA material adverse repricing or non-renewal of the CVS supply agreement, a discl...
-
Scenario-weighted conviction
| Probability | Score | Contribution | |
|---|---|---|---|
| Bull case | 37% | 100 / 100 | 37.0 |
| Base case | 50% | 62 / 100 | 31.0 |
| Bear case | 13% | 10 / 100 | 1.3 |
| Weighted conviction | 69 / 100 - BUY | ||
Top risks
- Binding letter of intent to extend pharmaceutical distribution agreements with CVS Health through June 30, 2032
- Two tuck-in acquisitions to expand home care business
- Q4 FY2026 diluted EPS of $2.91 (up 40% YoY) and full-year adjusted free cash flow of $5 billion with FY2027 guidance provided